BioBonds Use Wall Street Tools to Fund Medical Research

In the development of disease treatments, the phase between basic research and advanced clinical trials is known as the “valley of death.” While numerous public grants fund early-stage research, and pharmaceutical companies are willing to fund studies of proven solutions, funding “translational” research where key findings apply to potential treatments is notoriously difficult. As a …